{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:44:32Z","timestamp":1787701472307,"version":"build-2784847793"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"1159","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Quanzhou High-level Talents Innovation and Entrepreneurship","award":["2021C045R"],"award-info":[{"award-number":["2021C045R"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Prostate biopsies are mainly performed through transrectal or perineal approaches, while ultrasound probes are located in the rectum for guidance. However, reports on the use of perineal ultrasound-guided transperineal prostate biopsy (PG-TPPB) are few.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective case-control study was designed. A total of 111 patients who underwent PG-TPPB from February 2019 to December 2020 were investigated retrospectively. Simultaneously, 188 patients who underwent transrectal prostate biopsy (TRPB) were included as control. The prostate cancer detection rates (PCDR), complication rates, and application values were compared between the 2 groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The overall PCDR in the PG-TPPB and TRPB groups were 33.3% (37\/111) and 39.9% (75\/188), respectively (P\u2009=\u2009.258). There was no significant difference in the PCDR between the 2 groups under each prostate-specific antigen level (all P\u2009&amp;gt;\u2009.05). The single-needle PCDR in the PG-TPPB and TRPB groups were 21.5% (277\/1 287) and 24.0% (513\/2 134), respectively (P\u2009=\u2009.091). The incidence of complications in the PG-TPPB group was significantly lower than that in the TRPB group (8.1% vs 21.3%, P\u2009=\u2009.003).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The PCDRs of PG-TPPB and TRPB were the same. However, the postoperative complication rate of PG-TPPB was significantly lower than that of TRPB. Moreover, PG-TPPB required simpler equipment and did not require enema administration, which is suitable for patients with rectal contraindications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Advances in knowledge<\/jats:title>\n                  <jats:p>The reports on PG-TPPB are few. Our study indicated that PG-TPPB reduced the postoperative complication rate. Moreover, PG-TPPB required simpler equipment. Importantly, PG-TPPB is suitable for patients with rectal contraindications.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjr\/tqae097","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:39:23Z","timestamp":1716493163000},"page":"1351-1356","source":"Crossref","is-referenced-by-count":4,"title":["A novel simplified transperineal prostate biopsy guided by perineal ultrasound"],"prefix":"10.1093","volume":"97","author":[{"given":"Yang","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of Ultrasonography, The Second Affiliated Hospital of Fujian Medical University , Quanzhou, 362000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Ultrasonography, The Second Affiliated Hospital of Fujian Medical University , Quanzhou, 362000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Ultrasonography, The Second Affiliated Hospital of Fujian Medical University , Quanzhou, 362000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobin","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Ultrasonography, The Second Affiliated Hospital of Fujian Medical University , Quanzhou, 362000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helin","family":"Ke","sequence":"additional","affiliation":[{"name":"Department of Ultrasonography, The Second Affiliated Hospital of Fujian Medical University , Quanzhou, 362000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaodan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Ultrasonography, The Second Affiliated Hospital of Fujian Medical University , Quanzhou, 362000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorong","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Ultrasonography, The Second Affiliated Hospital of Fujian Medical University , Quanzhou, 362000, China"},{"name":"Department of Medicine, Quanzhou Medical College , Quanzhou, 362000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1195-2245","authenticated-orcid":false,"given":"Shilin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ultrasonography, The Second Affiliated Hospital of Fujian Medical University , Quanzhou, 362000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"issue":"3","key":"2024061918460720600_tqae097-B1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2024061918460720600_tqae097-B2","doi-asserted-by":"crossref","first-page":"872411","DOI":"10.3389\/fendo.2022.872411","article-title":"Zinc-loaded black phosphorus multifunctional nanodelivery system combined with photothermal therapy have the potential to treat prostate cancer patients infected with COVID-19","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2024061918460720600_tqae097-B3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/pros.23934","article-title":"Prostate cancer research: the next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting","volume":"80","author":"Miyahira","year":"2020","journal-title":"Prostate"},{"key":"2024061918460720600_tqae097-B4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.semcancer.2017.03.009","article-title":"Cellular determinants and microenvironmental regulation of prostate cancer metastasis","volume":"44","author":"Rycaj","year":"2017","journal-title":"Semin Cancer Biol"},{"issue":"16","key":"2024061918460720600_tqae097-B5","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMms1914228","article-title":"Reconsidering prostate cancer mortality\u2014the future of PSA screening","volume":"382","author":"Welch","year":"2020","journal-title":"N Engl J Med"},{"issue":"24","key":"2024061918460720600_tqae097-B6","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2017.7248","article-title":"The diagnosis and treatment of prostate cancer: a review","volume":"317","author":"Litwin","year":"2017","journal-title":"JAMA"},{"key":"2024061918460720600_tqae097-B7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0022-5347(17)38746-3","article-title":"Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen","volume":"142","author":"Kabalin","year":"1989","journal-title":"J Urol"},{"issue":"6","key":"2024061918460720600_tqae097-B8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MOU.0000000000000678","article-title":"Optimizing prostate biopsy techniques","volume":"29","author":"Omer","year":"2019","journal-title":"Curr Opin Urol"},{"issue":"11","key":"2024061918460720600_tqae097-B9","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s00345-020-03112-3","article-title":"Infectious complications of prostate biopsy: winning battles but not war","volume":"38","author":"Derin","year":"2020","journal-title":"World J Urol"},{"issue":"12","key":"2024061918460720600_tqae097-B10","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1007\/s10147-021-02010-x","article-title":"Risk assessment of multi-factorial complications after transrectal ultrasound-guided prostate biopsy: a single institutional retrospective cohort study","volume":"26","author":"Utsumi","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"2024061918460720600_tqae097-B11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/JU.0000000000002497","article-title":"The effect of different types of prostate biopsy techniques on post-biopsy infectious complications","author":"Tops","year":"2022","journal-title":"J Urol"},{"issue":"4","key":"2024061918460720600_tqae097-B12","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.juro.2010.11.088","article-title":"Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy","volume":"185","author":"Liss","year":"2011","journal-title":"J Urol"},{"issue":"6","key":"2024061918460720600_tqae097-B13","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/JU.0000000000000156","article-title":"Transperineal prostate biopsies using local anesthesia: experience with 1,287 patients. prostate cancer detection rate, complications and patient tolerability","volume":"201","author":"Stefanova","year":"2019","journal-title":"J Urol"},{"issue":"4","key":"2024061918460720600_tqae097-B14","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bju.13031","article-title":"Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: the Victorian Transperineal Biopsy Collaboration experience","volume":"116","author":"Ong","year":"2015","journal-title":"BJU Int"},{"issue":"1","key":"2024061918460720600_tqae097-B15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ucl.2020.09.010","article-title":"Recent advances and current role of transperineal prostate biopsy","volume":"48","author":"Bhanji","year":"2021","journal-title":"Urol Clin North Am"},{"issue":"6","key":"2024061918460720600_tqae097-B16","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4103\/aja.aja_16_19","article-title":"Comparison of diagnostic efficacy between transrectal and transperineal prostate biopsy: a propensity score-matched study","volume":"21","author":"Jiang","year":"2019","journal-title":"Asian J Androl"},{"issue":"4","key":"2024061918460720600_tqae097-B17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/end.2020.1093","article-title":"\u201cFree-Hand\u201d transperineal prostate biopsy under local anesthesia: review of the literature","volume":"35","author":"Szabo","year":"2021","journal-title":"J Endourol"},{"issue":"1","key":"2024061918460720600_tqae097-B18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12957-019-1573-0","article-title":"Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"17","author":"Xiang","year":"2019","journal-title":"World J Surg Oncol"},{"issue":"5","key":"2024061918460720600_tqae097-B19","doi-asserted-by":"crossref","first-page":"191.e9-191","DOI":"10.1016\/j.urolonc.2022.01.004","article-title":"Comparisons of efficacy and complications between transrectal and transperineal prostate biopsy with or without antibiotic prophylaxis","volume":"40","author":"He","year":"2022","journal-title":"Urol Oncol"},{"issue":"5","key":"2024061918460720600_tqae097-B20","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.euf.2020.11.006","article-title":"Comparison of complication rates with antibiotic prophylaxis with cefpodoxime versus fluoroquinolones after transrectal prostate biopsy","volume":"7","author":"Wenzel","year":"2021","journal-title":"Eur Urol Focus"}],"container-title":["British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/advance-article-pdf\/doi\/10.1093\/bjr\/tqae097\/57909277\/tqae097.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/97\/1159\/1351\/58280369\/tqae097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/97\/1159\/1351\/58280369\/tqae097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T18:46:45Z","timestamp":1718822805000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/97\/1159\/1351\/7680535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":20,"journal-issue":{"issue":"1159","published-online":{"date-parts":[[2024,5,23]]},"published-print":{"date-parts":[[2024,6,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bjr\/tqae097","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"value":"0007-1285","type":"print"},{"value":"1748-880X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,5,23]]}}}